{
    "organizations": [],
    "uuid": "6b2c8bbb81a862f9434e3f1ebc99c18e9aee697b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sellas-life-sciences-receives-fda/brief-sellas-life-sciences-receives-fda-orphan-drug-designation-for-galinpepimut-s-for-treatment-of-multiple-myeloma-idUSASC0A16I",
    "ord_in_thread": 0,
    "title": "BRIEF-Sellas Life Sciences Receives FDA Orphan Drug Designation For Galinpepimut-S For Treatment Of Multiple Myeloma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Sellas Life Sciences Group Inc:\n* SELLAS LIFE SCIENCES RECEIVES FDA ORPHAN DRUG DESIGNATION FOR GALINPEPIMUT-S (GPS) FOR TREATMENT OF MULTIPLE MYELOMA (MM) Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:42:00.000+03:00",
    "crawled": "2018-05-10T17:24:27.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sellas",
        "life",
        "science",
        "group",
        "inc",
        "sellas",
        "life",
        "science",
        "receives",
        "fda",
        "orphan",
        "drug",
        "designation",
        "gps",
        "treatment",
        "multiple",
        "myeloma",
        "mm",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}